First add-on perampanel for focal-onset seizures: An open-label, prospective study (vol 141, pg 132, 2020)

被引:0
|
作者
Kim, J. H.
Kim, D. W.
Lee, S. K.
Seo, D. W.
Lee, J. W.
Park, H. J.
Lee, S. A.
机构
来源
ACTA NEUROLOGICA SCANDINAVICA | 2020年 / 142卷 / 04期
关键词
D O I
10.1111/ane.13309
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:396 / 397
页数:2
相关论文
共 50 条
  • [42] Long-term safety of pregabalin add-on treatment in patients with partial-onset seizures: pooled analysis of six open-label clinical studies
    Leon, T.
    Uthman, B.
    Bazil, C.
    Schulze-Bonhage, A.
    Whalen, E.
    Emir, B.
    Benabou, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 89 - 90
  • [43] Study 512 Design: Perampanel as first adjunctive therapy in patients aged ≥12 years with focal-onset seizures or generalised tonic-clonic seizures associated with genetic generalised epilepsy
    Burd, S.
    Assenza, G.
    Quintas, S.
    Gil Lopez, F. J.
    Wagner, J.
    Patten, A.
    Sainz-Fuertes, R.
    Lagarde, S.
    Sejbaek, T.
    Vlasov, P.
    Kharkovskiy, V.
    Lebedeva, A.
    EPILEPSIA, 2023, 64 : 293 - 293
  • [44] Long-term treatment with Perampanel of Chinese patients with focal-onset seizures, especially in sleep-related epilepsy: a prospective real-world observational study
    Xu, Ye
    Wang, Qinyue
    Zhang, Yufei
    Chen, Yuncan
    Xu, Lan
    Zhu, Guoxing
    Ma, Chunlai
    Wu, Xunyi
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [45] Study 512 design: A prospective, observational, multicentre study of perampanel as first adjunctive therapy in routine clinical care of patients aged ≥12 years with focal-onset seizures or generalised tonic-clonic seizures associated with idiopathic generalised epilepsy
    Burd, S.
    Assenza, G.
    Quintas, S.
    Gil Lopez, F. J.
    Wagner, J.
    Patten, A.
    Sainz-Fuertes, R.
    Lagarde, S.
    Sejbaek, T.
    Vlasov, P.
    Kharkovskiy, V.
    Lebedeva, A.
    EPILEPSIA, 2022, 63 : 141 - 141
  • [46] Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures
    Fogarasi, Andras
    Flamini, Robert
    Milh, Mathieu
    Phillips, Steven
    Yoshitomi, Shinsaku
    Patten, Anna
    Takase, Takao
    Laurenza, Antonio
    Ngo, Leock Y.
    EPILEPSIA, 2020, 61 (01) : 125 - 137
  • [47] Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study
    Althobaiti, Fahad M.
    Alsanosi, Safaa M.
    Falemban, Alaa H.
    Alzahrani, Abdullah R.
    Fataha, Salma A.
    Salih, Sara O.
    Alrumaih, Ali M.
    Alotaibi, Khalid N.
    Althobaiti, Hazim M.
    Al-Ghamdi, Saeed S.
    Ayoub, Nahla
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [48] RUFINAMIDE IN CHILDREN WITH LENNOX-GASTAUT SYNDROME AND OTHER RELATED REFRACTORY EPILEPTIC ENCEPHALOPATHIES: A PROSPECTIVE, ADD-ON, OPEN-LABEL TREATMENT STUDY
    Cantarin, V.
    Garcia-Penas, J.
    Ruiz-Falco, M.
    Lara-Herguedas, J.
    Duat-Rodriguez, A.
    Lopez-Marin, L.
    Gutierrez-Solana, L.
    Rodrigo, M.
    Gutierrez, N.
    Perez-Jimenez, M.
    EPILEPSIA, 2009, 50 : 149 - 149
  • [49] Study 410 Enrollment Update: Multicenter, Open-Label, Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS)
    Klein, Pavel
    Williams, Betsy
    Laurenza, Antonio
    Patten, Anna
    Malhotra, Manoj
    NEUROLOGY, 2019, 92 (15)
  • [50] Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study
    Poisson, Kelsey
    Wong, Matthew
    Lee, Chon
    Cilio, Maria Roberta
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2020, 25 : 77 - 81